← Leaderboards
Emmanuel Walter
Duke University
$27,178,392
Attributed
$27,178,392
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $9.9M · FY2018–23$10M$7.5M$5M$2.5M$0
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$27,178,392 · 2
By mechanism
N01$19,283,736 · 2
N02$7,894,656 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Barton F Haynes$531,570,874
- John H Sampson$43,413,436
- Michael Barry Kastan$65,974,699
- Emmanuel B Walter$22,544,318
- Scott M Palmer$46,531,610
Others in their field
Other Emerging Leaders on “Design”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- John E West · University Of Texas At Austin$113,883,001
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Kevin Urdahl · Seattle Children'S Hospital$72,239,698
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
Research focus
DesignVaccinesProgramsConduct Clinical TrialsContractsResourcesCombatCommunicable DiseasesProtocol DevelopmentEvaluationInfluenza Virus VaccineNational Institute Of Allergy And Infectious DiseaseUniversal Influenza VaccineOperationInnovationNamed GroupClinical Trials NetworkClinical CenterInfluenzaSoundClinical TrialsClinical ResearchResearch ActivityNatural History
Grant awards (12)
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL CORE$3,484,773
N01 · FY2023 · AI · contact PI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL CORE$2,171,634
N01 · FY2022 · AI · contact PI
Vaccine and Treatment Evaluation Units: Overall Administration, Clinical Operations Support, Protocol Development, Implementation and Assays$103,618
N01 · FY2022 · AI · contact PI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL CORE$3,667,392
N01 · FY2021 · AI · contact PI
Vaccine and Treatment Evaluation Units: Overall Administration, Clinical Operations Support, Protocol Development, Implementation and Assays$102,121
N01 · FY2021 · AI · contact PI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL CORE$6,899,386
N01 · FY2020 · AI · contact PI
Vaccine and Treatment Evaluation Units: Overall Administration, Clinical Operations Support, Protocol Development, Implementation and Assays$318,357
N01 · FY2020 · AI · contact PI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL CORE$7,894,656
N02 · FY2019 · AI · contact PI
Vaccine and Treatment Evaluation Units: Protocol Development and Implementation for Natural History Challenge Studies for Influenza$934,569
N01 · FY2019 · AI · contact PI
Vaccine and Treatment Evaluation Units: Protocol Development and Implementation for a Phase I Vaccine Trial for Influenza$705,509
N01 · FY2019 · AI · contact PI
Vaccine and Treatment Evaluation Units: Overall Administration, Clinical Operations Support, Protocol Development, Implementation and Assays$412,260
N01 · FY2019 · AI · contact PI
Vaccine and Treatment Evaluation Units$484,117
N01 · FY2018 · AI · contact PI